For certain side effects of complex and lifesaving medical procedures, care teams can be left with limited and risky treatment options, but a program at UW Health is changing that using patients’ own cells as “living …

Don and Marilyn Anderson Professor of Oncology and Associate Dean for Therapeutics Development, University of Wisconsin in Madison, US Galipeau is the president-elect of the International Society for Cell Therapy and the director of the …

Several members of PACT’s staff recently attended the 2022 Annual Meeting of the International Society for Cell & Gene Therapy, May 4-7, 2022, in San Francisco, CA. From bench research to cell manufacturing, many aspects …

PACT Director Jacques Galipeau, MD, FRCP, was officially inducted as President of the International Society of Cell and Gene Therapy at their annual meeting in San Francisco, May 4-7, 2022. Galipeau officially replaces Bruce Levine, …

The Program for Advanced Cellular Therapy is excited to announce the promotion of Andrea Pennati, Ph.D., to Director of Research and Development. In this role, Dr. Pennati is responsible for the transition of UW’s pre-clinical …

Jacques Galipeau, MD, FRCP, PACT Director, recently presented at the Department of Neurosurgery Grand Rounds. The full presentation, “Mesenchymal Stromal Cells for TBI – A first-in-human clinical trial proposal,” can be viewed below:    

Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …

In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …